Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRODUCT LIFE LINE CURVE
2.7 MULTIVARIATE MODELLING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 DBMR MARKET CHALLENGE MATRIX
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 RAW MATERIAL OUTLOOK
4.2 ADOPTION SCENARIO AMONG BUYERS
4.3 VALUE CHAIN ANALYSIS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWTH IN PHARMACEUTICAL, AND HEALTHCARE SECTOR ACROSS THE GLOBE
5.1.2 RISE IN PRODUCTION OF INNOVATIVE GENERIC DRUGS, PARTICULARLY IN EMERGING ECONOMIES
5.1.3 INCREASE IN DEMAND FOR ALCOHOL SOLVENTS FOR MANUFACTURING OF VARIOUS DRUGS
5.2 RESTRAINTS
5.2.1 HIGH PRODUCTION COSTS, AND COMPLEX MANUFACTURING PROCESS
5.2.2 STRINGENT REGULATIONS REGARDING THE USE OF CERTAIN CONVENTIONAL SOLVENTS
5.3 OPPORTUNITIES
5.3.1 GROWTH IN RESEARCH AND DEVELOPMENT ACTIVITIES
5.3.2 DEVELOPMENT OF NEW DRUG MANUFACTURING METHODS AND TECHNOLOGIES
5.3.3 RISE IN ADOPTION OF GREEN MATERIALS AND CHEMICALS FOR DRUG MANUFACTURING
5.4 CHALLENGES
5.4.1 RISE IN CONCERNS REGARDING THE TOXICITY OF SOLVENTS
5.4.2 OCCURRENCES OF FATALITIES IN THE PHARMACEUTICAL SOLVENT MANUFACTURING COMPANIES
6 ANALYSIS ON IMPACT OF COVID-19 ON THE MARKET
6.1 AFTERMATH OF COVID-19 AND THE GOVERNMENT INITIATIVE TO BOOST THE MARKET
6.2 STRATEGIC DECISIONS OF MANUFACTURERS AFTER COVID-19 TO GET COMPETITIVE MARKET SHARE
6.3 IMPACT ON PRICE
6.4 IMPACT ON DEMAND
6.5 IMPACT ON SUPPLY CHAIN
6.6 CONCLUSION
7 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 ALCOHOL
7.2.1 METHANOL
7.2.2 ETHANOL
7.2.3 1-BUTANOL
7.2.4 2-BUTANOL
7.2.5 2-METHOXYETHANOL
7.2.6 3-METHYL-1-PROPANOL
7.2.7 2-METHYL-1-PROPANOL
7.2.8 1-PENTANOL
7.2.9 1-PROPANOL
7.2.10 2-PROPANOL (ISOPROPYL ALCOHOL)
7.2.11 OTHERS
7.3 AROMATIC HYDROCARBONS
7.3.1 TOLUENE
7.3.2 XYLENE
7.3.3 ETHYLBENZENE
7.3.4 OTHERS
7.4 KETONES
7.4.1 ACETONE
7.4.2 CYCLOHEXANONE
7.4.3 METHYL ETHER KETONE
7.4.4 METHYL ETHYL KETONE
7.4.5 METHYL ISOBUTYL KETONE
7.4.6 OTHERS
7.5 ETHERS
7.5.1 DIETHYL ETHER
7.5.2 METHOXYETHANE
7.5.3 TETRAHYDROFURAN
7.5.4 METHYL TERT-BUTYL ETHER
7.5.5 DI-N-PROPYL ETHER
7.5.6 OTHERS
7.6 AMINE
7.6.1 MONOETHANOLAMINE (MEA)
7.6.2 DIETHANOLAMINE (DEA)
7.6.3 METHYLDIETHANOLAMINE (MDEA)
7.6.4 OTHERS
7.7 ESTERS
7.7.1 ACETYL ACETATE
7.7.2 ETHYL ACETATE
7.7.3 BUTYL ACETATE
7.7.4 OTHERS
7.8 CHLORINATED SOLVENTS
7.8.1 TRICHLOROETHYLENE (TCE)
7.8.2 PERCHLOROETHYLENE (PCE)
7.8.3 1,1,1-TRICHLOROETHANE (TCA)
7.8.4 OTHERS
7.9 OTHERS
8 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 PHARMACEUTICAL
8.3 RESEARCH LABORATORIES
8.4 CHEMICAL
8.5 OTHERS
9 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET
9.1 NORTH AMERICA
9.1.1 U.S.
9.1.2 CANADA
9.1.3 MEXICO
10 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
10.2 MERGERS & ACQUISITIONS
10.3 EXPANSION
10.4 NEW PRODUCT DEVELOPMENT
10.5 PARTNERSHIP
10.6 AGREEMENTS
10.7 AWARD AND CERTIFICATION
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 ROYAL DUTCH SHELL PLC
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUS ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 BASF SE
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUS ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 MERCK KGAA
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 EXXON MOBIL CORPORATION
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 BRENNTAG SE
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENT
12.6 DUPONT
12.6.1 COMPANY SNAPSHOT
12.6.2 REVENUS ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 MITSUI CHEMICALS
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 RECENT DEVELOPMENT
12.8 DOW
12.8.1 COMPANY SNAPSHOT
12.8.2 REVENUS ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 LYONDELLBASELL INDUSTRIES HOLDINGS B.V.
12.9.1 COMPANY SNAPSHOT
12.9.2 REVENUS ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENT
12.1 CLARIANT AG
12.10.1 COMPANY SNAPSHOT
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENT
12.11 AVANTOR, INC.
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENT
12.12 EASTMAN CHEMICAL COMPANY
12.12.1 COMPANY SNAPSHOT
12.12.2 REVENUS ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENT
12.13 OLIN CORPORATION
12.13.1 COMPANY SNAPSHOT
12.13.2 REVENUE ANALYSIS
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENT
12.14 SK GEO CENTRIC CO., LTD. (A SUBSIDIARY OF SK NORTH AMERICA CHEMICAL)
12.14.1 COMPANY SNAPSHOT
12.14.2 PRODUCT PORTFOLIO
13 QUESTIONNAIRE
14 RELATED REPORTS
List of Table
TABLE 1 INNOVATORS OF GENERIC DRUGS
TABLE 2 DRUGS DEVELOPMENT IN THE YEAR 2021
TABLE 3 CLASSES OF SOLVENTS AND THEIR HARMFUL EFFECTS
TABLE 4 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 5 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 6 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 7 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 8 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 9 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 10 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 11 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 12 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 13 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 14 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 15 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 16 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 17 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 18 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 19 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS )
TABLE 20 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 21 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 22 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 23 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 24 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 25 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 26 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 27 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 28 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 29 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 30 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 31 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 32 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 33 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 34 NORTH AMERICA OTHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 35 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 36 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 37 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 38 NORTH AMERICA PHARMACEUTICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 39 NORTH AMERICA PHARMACEUTICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 40 NORTH AMERICA RESEARCH LABORATORIES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 41 NORTH AMERICA RESEARCH LABORATORIES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 42 NORTH AMERICA CHEMICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 43 NORTH AMERICA CHEMICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 44 NORTH AMERICA OTHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 45 NORTH AMERICA OTHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 46 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY COUNTRY, 2019-2028 (USD THOUSAND)
TABLE 47 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY COUNTRY, 2019-2028 (THOUSAND TONS)
TABLE 48 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 49 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 50 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 51 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 52 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 53 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 54 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 55 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 56 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 57 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 58 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 59 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 60 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 61 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 62 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 63 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 64 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 65 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 66 U.S. PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 67 U.S. PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 68 U.S. ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 69 U.S. ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 70 U.S. AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 71 U.S. AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 72 U.S. KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 73 U.S. KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 74 U.S. ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 75 U.S. ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 76 U.S. AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 77 U.S. AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 78 U.S. ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 79 U.S. ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 80 U.S. CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 81 U.S. CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 82 U.S. PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 83 U.S. PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 84 CANADA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 85 CANADA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 86 CANADA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 87 CANADA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 88 CANADA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 89 CANADA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 90 CANADA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 91 CANADA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 92 CANADA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 93 CANADA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 94 CANADA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 95 CANADA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 96 CANADA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 97 CANADA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 98 CANADA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 99 CANADA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 100 CANADA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 101 CANADA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 102 MEXICO PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 103 MEXICO PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 104 MEXICO ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 105 MEXICO ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 106 MEXICO AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 107 MEXICO AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 108 MEXICO KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 109 MEXICO KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 110 MEXICO ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 111 MEXICO ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 112 MEXICO AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 113 MEXICO AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 114 MEXICO ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 115 MEXICO ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 116 MEXICO CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 117 MEXICO CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 118 MEXICO PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 119 MEXICO PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
List of Figure
FIGURE 1 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: PRODUCT LIFELINE CURVE
FIGURE 7 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: MULTIVARIATE MODELLING
FIGURE 8 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: DBMR POSITION GRID
FIGURE 10 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 12 NORTH AMERICA PHARMACEUTICAL SOLVENT: THE MARKET CHALLENGE MATRIX
FIGURE 13 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: SEGMENTATION
FIGURE 14 ASIA-PACIFIC REGION IS EXPECTED TO DOMINATE THE NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, AND TO GROW WITH THE HIGHEST CAGR FROM 2021 TO 2028
FIGURE 15 THE GROWING PHARMACEUTICAL AND HEALTHCARE SECTOR ACROSS THE GLOBE IS DRIVING THE GROWTH OF THE NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 16 ALCOHOL SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET IN 2021 & 2028
FIGURE 17 VALUE CHAIN OF PHARMACEUTICAL SOLVENT
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET
FIGURE 19 WORLDWIDE GDP PER CAPITA INCOME
FIGURE 20 NEW DRUGS APPROVED BY THE U.S. FOOD AND DRUG ADMINISTRATION (2010-2020)
FIGURE 21 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT, 2020
FIGURE 22 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY APPLICATION, 2020
FIGURE 23 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: SNAPSHOT (2020)
FIGURE 24 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY COUNTRY (2020)
FIGURE 25 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 26 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 27 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT (2021-2028)
FIGURE 28 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: COMPANY SHARE 2020 (%)
